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Glucose is the main energetic substrate for the metabolic activity of brain cells and its
proper delivery into the extracellular space is essential for maintaining normal neural
functions. Under physiological conditions, glucose continuously enters the extracellular
space from arterial blood via gradient-dependent facilitated diffusion governed by
the GLUT-1 transporters. Due to this gradient-dependent mechanism, glucose levels
rise in the brain after consumption of glucose-containing foods and drinks. Glucose
entry is also accelerated due to local neuronal activation and neuro-vascular coupling,
resulting in transient hyperglycemia to prevent any metabolic deficit. Here, we explored
another mechanism that is activated during general anesthesia and results in significant
brain hyperglycemia. By using enzyme-based glucose biosensors we demonstrate that
glucose levels in the nucleus accumbens (NAc) strongly increase after iv injection of
Equthesin, a mixture of chloral hydrate and sodium pentobarbital, which is often used for
general anesthesia in rats. By combining electrochemical recordings with brain, muscle,
and skin temperature monitoring, we show that the gradual increase in brain glucose
occurring during the development of general anesthesia tightly correlate with decreases
in brain-muscle temperature differentials, suggesting that this rise in glucose is related
to metabolic inhibition. While the decreased consumption of glucose by brain cells
could contribute to the development of hyperglycemia, an exceptionally strong positive
correlation (r = 0.99) between glucose rise and increases in skin-muscle temperature
differentials was also found, suggesting the strong vasodilation of cerebral vessels as the
primary mechanism for accelerated entry of glucose into brain tissue. Our present data
could explain drastic differences in basal glucose levels found in awake and anesthetized
animal preparations. They also suggest that glucose entry into brain tissue could be
strongly modulated by pharmacological drugs via drug-induced changes in metabolic
activity and the tone of cerebral vessels.
Keywords: brain and body hypothermia, metabolic brain inhibition, anesthesia, vasoconstriction, vasodilation,
nucleus accumbens, rats
Bola and Kiyatkin Brain Hyperglycemia during General Anesthesia
INTRODUCTION
Glucose is the main energetic substrate for the metabolic
activity of brain cells (Siesjo, 1978; Sokoloff, 1999; Mergenthaler
et al., 2013) and its proper delivery into the extracellular space
is essential for maintaining normal neural functions. Unlike
most neurochemicals that are locally synthetized and released
either with the synapse or into the extracellular space due
to neural activation, glucose enters the brain tissue from the
arterial blood via gradient-dependent facilitated diffusion via
the GLUT-1 glucose transporter (Duelli and Kuschinsky, 2001).
Under physiological conditions, glucose entry into brain tissue
is governed by two primary mechanisms. First, glucose levels
in the extracellular space increase due to global rises in blood
glucose concentrations (de Vries et al., 2003; Dunn-Meynell
et al., 2009; Dash et al., 2013). Such “passive” increases occur
during consumption of glucose-containing products and intra-
gastric glucose or systemic glucose injections, and they are slow
and relatively large, directly depending upon the amount of
ingested or injected glucose (Wakabayashi and Kiyatkin, 2015a).
In addition to this slow, gradient-dependent mechanism, glucose
could rapidly enter the brain due to increases in local blood flow
resulting from proximal neural activation (Fellows et al., 1992;
Silver and Erecinska, 1994; Attwell et al., 2010). These increases
are much more rapid, but less in magnitude (20–100µM) and
more transient (Kiyatkin and Lenoir, 2012).
Here, we provide evidence for another mechanism that is
activated during general anesthesia and determines robust entry
of glucose into brain tissue due to vasodilation of cerebral vessels.
First, by using enzyme-based glucose biosensors coupled with
amperometry, we demonstrate that the development of general
anesthesia results in a rapid, robust, and prolonged rise in
extracellular glucose levels in the nucleus accumbens shell (NAc).
Second, by simultaneous temperature recordings from the NAc,
temporal muscle, and skin, we show that general anesthesia
results in robust decreases in brain and body temperatures
and clarify its two underlying mechanisms: decrease in intra-
brain heat production due to metabolic inhibition and increase
in heat loss due to vasodilation. Finally, by using correlation
and regression analyses, we show a tight correlation between
increases in NAc glucose levels and Skin-Muscle temperature
differentials, a validmeasure of peripheral vasodilation (Kiyatkin,
2010). We chose the NAc, a critical structure in integrating
sensory and motor processes for behavioral output (Mogenson
et al., 1980; Wise and Bozarth, 1987), as a representative
deep brain structure for our electrochemical and temperature
recordings. Based on these data, we assume that the robust rise
in brain glucose occurring during general anesthesia results from
powerful dilation of cerebral vessels, which enhances glucose
entry from the arterial blood into the brain’s extracellular space.
The effect of anesthesia could explain the existing controversy
regarding basal glucose levels in brain tissue determined in
awake and anesthetized animal preparations (see McNay et al.,
2001; Routh, 2002 for details) and question the validity of
findings on fluctuations in extracellular glucose obtained in
anesthetized animals. The knowledge on true concentrations of
brain glucose under physiologically relevant conditions is also
important for understanding of glucose sensing by brain cells and
for providing optimal conditions for in vitro assessment of neural
activity.
MATERIALS AND METHODS
Animals and Housing
Forty-five male Long-Evans rats (440± 40 g) supplied by Charles
River Laboratories (Greensboro, NC) were housed individually
in a temperature-, humidity-, and light-controlled room (12/12 h
light/dark cycle, lights on at 07:00) with free access to food and
water. Protocols were performed in compliance with the Guide
for the Care and Use of Laboratory Animals (NIH, Publication
865-23) and were approved by the NIDA-IRP Animal Care and
Use Committee.
General Structure of the Study
Our previous experiments using enzyme-based glucose
biosensors were conducted in awake, freely moving rats
and in most cases animals were equipped with intravenous
(iv) catheter. Since post-recording sensor calibration is an
essential part of our experimental paradigm, at the final stage
of these experiments rats were injected with 0.8–0.9ml of
Equithesin to induce general anesthesia and remove safely
the sensor for calibration. Equithesin is a general anesthetic
preparation that is often used during surgeries in rats; its active
ingredients are sodium pentobarbital and chloral hydrate,
(9.7 and 44.4mg/ml, respectively). Since the analgesic and
behavior-blocking effects of this treatment occur at the end of
the injection, our electrochemical recordings continued for at
least 8min. Data obtained during these recordings composed the
first data set of the present study.
The robust changes in NAc glucose we consistently observed
in these experiments led us to conduct a second experiment,
in which we examined the effects of Equithesin administered
at the same dose, route of administration, and injection speed
on NAc glucose levels during long-term recording. In this
experiment, we also conducted several control tests to examine
the possible mechanisms underlying the observed dynamics of
glucose fluctuations. This experiment produced the second data
set of the present study.
To further understand the possible mechanisms underlying
robust anesthesia-induced changes in glucose, we conducted
the third experiment, in which we examined temperature
changes in NAc, temporal muscle, and skin induced by
iv injections of Equithesin used at the same dose and
administration route. While it is known that general anesthesia
induces hypothermia and we previously examined this effect
using intraperitoneal (ip) injections of sodium pentobarbital
(50mg/kg; Kiyatkin and Brown, 2005), the three-point recording
paradigm allowed us to examine the dynamics of two primary
variables underlying the hypothermic effects of anesthesia: intra-
brain heat production and vascular tone. These data were used to
conduct correlative and regression analyses aimed to examine the
possible mechanisms responsible for specific changes in glucose
found in our electrochemical experiments.
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Common Procedures in all Experiments
In all experiments, rats were implanted with a chronic jugular
catheter, which ran subcutaneously to a head mount constructed
specifically for either experiment (see below), made from dental
acrylic and secured to the skull by three stainless steel bone
screws. Rats were allowed a minimum of 4 days of post-
operative recovery; jugular catheters were flushed daily with
0.2ml heparinized saline (10 units/ml) to maintain patency. At
the onset of each experiment, the injection port of the jugular
catheter on the head mount was connected to plastic catheter
extensions that allowed stress- and cue-free delivery of tested
substances from outside the chamber, thus minimizing possible
detection of the injection procedure by the rat.
All rats underwent similar habituation to the testing
environment (a minimum of 6 h a day for 3 consecutive days)
prior to the recording sessions. Recording experiments began 5
days after surgery and were conducted during the light-phase
of the cycle (10:00–17:00). All recordings were conducted in
standard chambers (38 × 47 × 47 cm) under continuous dim
illumination (20W red light bulb), with a room wide air filter fan
providing background noise.
In each experiment, rats received either one or two iv
injections of Equithesin (0.8–0.9ml depending on animal weight
or 18mg/kg for sodium pentobarbital plus 84mg/kg for chloral
hydrate), which was delivered at the same speed and duration
(120 s) with minimal possible stressful or arousing influence of
the injection procedure.
Electrochemical Experiments (I and II)
Surgical Preparations
Each rat used in these experiments was surgically prepared for
electrochemical recordings as described in detail previously
(Kiyatkin and Lenoir, 2012; Wakabayashi and Kiyatkin,
2014, 2015a). Briefly, under general anesthesia (Equithesin
0.33ml/100 g, ip), rats were implanted with a BASi cannula
(Bioanalytical Systems, Inc.; West Lafayette, IN, USA) for
future insertions of a biosensor in the medial sector of the
nucleus accumbens (NAc shell). The target coordinates were:
AP +1.2mm, ML ± 0.8mm and DV 7.3mm, according to
the stereotaxic atlas of Paxinos and Watson (1998). The guide
cannula hub was fixed to the skull with a headmount constructed
from dental acrylic that was secured using three stainless steel
bone screws.
Fixed-Potential Amperometry with Enzyme-Based
Glucose Sensors
Commercially produced glucose oxidase-based biosensors
(Pinnacle Technology, Inc., Lawrence, KS, USA) coupled with
fixed-potential amperometry have been extensively used in our
previous studies (Kiyatkin and Lenoir, 2012; Kiyatkin et al.,
2013; Kiyatkin and Wakabayashi, 2015; Wakabayashi and
Kiyatkin, 2015a,b). These reports describe in detail multiple
issues regarding the sensitivity/selectivity of these sensors, their
in vitro and in vivo performance, and possible physical and
chemical contributions that could be evaluated and controlled
for providing high reliability and accuracy of electrochemical
measurements of extracellular glucose fluctuations.
Briefly, glucose sensors are prepared from Pt-Ir wire of
180µm diameter, with a sensing cavity of ∼1mm length on
its tip. The active electrode is incorporated with an integrated
Ag/AgCl reference electrode. On the active surface, glucose
oxidase converts glucose to glucono-1,5-lactone and hydrogen
peroxide (H2O2), which is detected as an amperometric
oxidation current generated by a +0.6V applied potential (Hu
andWilson, 1997). The potential contribution of ascorbic acid to
the measured current is competitively reduced by co-localizing
ascorbic acid oxidase enzymes on the active surface of the
sensor. This enzyme converts ascorbic acid to non-electroactive
dehydroascorbate and water. In addition, a negatively charged
Nafion polymer layer under the enzyme layer serves to exclude
endogenous anionic compounds (Hu and Wilson, 1997).
Glucose sensors were calibrated immediately before and after
each in vivo experiment. In vitro calibrations were conducted
in PBS (pH 7.3) at room temperature (23◦C) by incrementally
increasing the concentration of glucose (Sigma-Aldrich) from
0 to 0.5, 1.0, and 1.5mM followed by a single addition of
ascorbate (25 or 250µM). Within the physiological range
of glucose levels (Fellows and Boutelle, 1993; McNay et al.,
2001), glucose sensors produced incremental linear current
increases, with a mean sensitivity of 3.12 ± 0.27 nA/0.5mM.
Glucose sensors showed low sensitivity to ascorbate (0.17 ±
0.06 nA/25µM) and, as showed previously, they were only
minimally sensitive to dopamine at its physiological levels (5-
50 pA/10–100 nM). As shown previously (see Kiyatkin and
Wakabayashi, 2015), glucose sensors remained equally sensitive
to glucose and selective against ascorbate during post-recording
in vitro calibrations. Since the sensitivity of electrochemical
sensors is greatly affected by temperature, our calibration data
were adjusted to 37◦C (6.12 ± 0.52 nA/0.5mM) based on
a temperature coefficient previously determined in analytical
in vitro tests. Although our previous data suggest that both
physical and chemical contributions to glucose electrochemical
currents are minimal, we also conducted the same tests using
enzyme-free or null sensors. Data obtained with these sensors
were used for more precise determination of basal levels of
glucose and its fluctuations in terms of concentration.
Protocol
At the beginning of each experimental session in Experiments I
and II, rats wereminimally anesthetized (<2min) with isoflurane
and a calibrated glucose or null sensor was inserted into the
brain through the guide cannula. The sensor was connected
to the potentiostat (Model 3104, Pinnacle Technology) via an
electrically shielded flexible cable and a multi-channel electrical
swivel. Additionally, the injection port of the jugular catheter on
the head mount was connected to a plastic catheter extension
that allowed stress- and cue-free drug delivery from outside the
chamber.
The first set of electrochemical data (Experiment I) was
obtained during analyses of our previous experiments obtained
in awake, freely moving rats that received a single iv injection
of Equithesin as the final experimental event. The injection was
conducted when the rat was in quiet resting conditions ∼7–8 h
after the start of continuous recording. In Experiment II, rats
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received two iv injections of Equithesin with an inter-injection
interval of at least 120min. In this experiment, we also used one
or two tests with a novel object to verify the sensor’s performance
and observe the pattern of NAc glucose responses induced by
arousing sensory stimulation. A small 50-ml glass beaker was
introducedmanually to the chamber and removed 60 s thereafter.
While the anesthetic drug in Experiment I was delivered at room
temperature, in Experiment II we also compared the effects of
anesthetic drug delivered at 23 and 37◦C. For the latter test,
the injection syringe was warmed in a water bath with strict
temperature monitoring. In this experiment, we also examined
the effects of saline delivered at room temperature at the volume
(0.85ml) identical to that used for Equithesin.
Data processing and Statistical Analyses for
Experiments I and II
Electrochemical data were sampled at 1Hz (i.e., mean current
over 1 s) using the PAL software (Version 1.5.0, Pinnacle
Technology) and analyzed using different time resolutions. Slow
changes in electrochemical currents were analyzed with 2-min
quantification bins using an analysis window of 20min before
and 120min after each iv injection. Rapid current changes
were analyzed with 2 and 10-s bins for specified durations
after the onset of each experimental event. Since the baseline
currents slightly varied in amplitude between individual glucose
electrodes, absolute current changes were transformed into
relative changes by taking a basal value before each event as 0
nA. These current changes were then transformed into glucose
concentration (µM) based on the sensor sensitivity determined
during pre-recording in vitro calibrations and adjusted by
the temperature coefficient (95.6%) determined in previous
analytical tests (Kiyatkin et al., 2013).
Statistical data analyses included the use of one-way repeated
measure (RM) ANOVAs to find time periods where there was
a significant post-injection main effect. Fisher post-hoc tests
were used for pair-wise comparisons, and the latency of the
glucose response was determined based on the first data point
significantly different from baseline (p < 0.05).
Thermorecording Experiment (III)
Surgical Preparations
Rats for this experiment underwent the three-point
thermocouple electrode implantation procedure described
in detail elsewhere (Kiyatkin et al., 2014). Briefly, under
general anesthesia, we implanted miniature copper-constantan
thermocouple probes (125µm in diameter) in the NAc shell
(AP +1.2mm; L 0.9mm; DV 7.2–7.4mm), deep temporal
muscle, and subcutaneously along the nasal ridge with the
tip∼15mm anterior to bregma. Testing chambers were equipped
with an electrical swivel and a flexible cable that attached to the
implanted thermoelectrodes during recording sessions.
Protocol
The experimental protocol was similar to that in Experiment
II. After ∼2-h habituation to the recording chamber, rats were
exposed to the novelty test (a 50-ml glass beaker presented for
60 s) and received a single injection of Equithesin 60min after. In
contrast to electrochemical recordings, when each rat was tested
during only one session, temperature recordings in each rat were
conducted during two sessions with one free day between them.
Temperature Data Analyses
Temperature data were continuously recorded at a 10-s
resolution using Thermes-16 (Physitemp Instruments). These
primary data were then analyzed at different time resolutions
as absolute changes, as changes relative to the immediate pre-
injection baseline values, and as NAc-Muscle and Skin-Muscle
temperature differentials (i.e., the difference between relative
temperature changes in the corresponding locations). Slow
changes in both temperature and locomotion were analyzed in
2-min quantification bins using an analysis window of 20min
before and 120min after each injection. Rapid changes were
analyzed in 10-s bins for 60 s before and 480 s after each iv drug
injection.
The brain and the temporal muscle receive arterial blood
from the same carotid artery and thus are equally exposed
to blood-delivered heat from the body. The NAc-Muscle
temperature differential excludes this common source of heat and
provides a measure of drug-induced metabolic brain activation
or inhibition. Skin temperature is determined by the state of
peripheral vessels, but also depends on the temperature of arterial
blood inflow. Therefore, Skin-Muscle temperature differentials
exclude the contribution of the latter and serve as an accurate
measure of peripheral vascular tone (Kiyatkin, 2010).
Temperature data were statistically analyzed by using one-
way RM ANOVAs to find time periods where there was
a significant post-injection main effect and individual bins
were compared with respect to baseline using Fisher post-
hoc tests. To examine the relationships between temperature
and neurochemical parameters, we also used correlation and
regression analyses.
RESULTS
Basal Levels of NAc Glucose and its
Changes Associated with the Initiation of
General Anesthesia
Our previous estimates of basal extracellular glucose levels in the
NAc ranged from 540µM (Kiyatkin and Lenoir, 2012) to 664µM
(Wakabayashi et al., 2015). These values were determined in
quietly resting rats before the first experimental event of each
study, ∼2.5-h after the start of in vivo recording. We also
previously reported that basal glucose levels became slightly
lower (∼80% of the initial baseline) when determined before the
last experimental event,∼7.5 h after the start of in vivo recording.
Our current analyses conducted for a relatively large data
sample (17 active and 15 null recordings) revealed that the basal
glucose values immediately before the injection of Equithesin
were: 535.5 ± 55.4µM (SD = 234.9µM). Figure 1 shows
how these basal glucose levels were determined. First, we
measured basal currents detected by both glucose and null
sensors immediately before the injection of an anesthetic drug
(Figure 1A). Second, we determined the difference between each
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FIGURE 1 | Graphic representation of data used to determine basal concentrations of extracellular glucose in the NAc. (A) shows the values of basal
electrochemical currents detected by active (enzume-containing) and null (enzyme-free) sensors as well as the range of glucose sensitivity (nA/0.5mM corrected for
37◦C) of active sensors. (B) shows the range of differences between active and null currents detected at the same time points. (C) shows the values of basal glucose
levels in this sample. See text for more detail explanations.
individual value of glucose current and the mean value of null
current (Figure 1B). Third, we calibrated these differences in
terms of concentration using the sensitivity values of each sensor
adjusted to 37◦C (Figures 1A,C).
As shown in Figure 2, injection of Equithesin induces a
bidirectional change in glucose currents with no changes in null
current (Figure 2A). After subtracting the values detected by null
sensors and calibrating the difference in terms of concentration
(Figure 2B), we found that glucose levels slightly decreased
during the injection but gradually and strongly increased
from∼150 s, reaching∼210µM at the final analysis point (8min
after injection onset). While one-way RM ANOVA applied to the
entire analysis interval revealed a significant increase [effect of
time: F(48,912) = 90.87; p < 0.001], the same analysis using a
sliding time window revealed that initially glucose significantly
decreased [F(15,285) = 7.71; p < 0.01], falling below baseline
from 55 to 145 s after the injection onset.
The Time-Course of NAc Glucose
Elevation during General Anesthesia
In Experiment II (six rats with active and two with null sensors),
we examined the time-course of the NAc glucose responses
induced by iv injection of Equithesin. Since two factors: a
relatively large volume of the injection and the cool temperature
of the injected volume could possibly contribute to certain
components of the glucose response, we tested the effects of saline
delivered at the same volumes and speed at room temperature,
and the effects of Equithesin delivered at room (23◦C) and body
(37◦C) temperatures. In this experiment, before drug or saline
injections, we also examined NAc glucose response induced by
an arousing stimulus; these data will be shown separately in the
last part of the Results Section.
As can be seen in Figure 3, an injection of anesthetic drug
at both temperatures induced robust and prolonged increases
in NAc glucose currents (Figures 3C,D) with no changes seen
FIGURE 2 | Mean (± SEM) changes in NAc electrochemical currents (A;
orange: glucose and blue: null sensors) and glucose concentration (B)
induced by iv injection of Equithesin. Gray area shows the duration of iv
injection (0–120 s). Filled symbols in (B) show values significantly different from
the pre-injection baseline (p < 0.05).
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FIGURE 3 | Original examples of changes in electrochemical currents detected by glucose (A–D) and null (E) sensors following novelty test (A,B,E) and
iv injections of Equithesin (C–E). Data were obtained with 1-s time resolution. Gray areas in each graph show the duration of stimulation or injection. Anesthetic
drug was delivered at 23 and 37◦C.
in null currents (Figure 3E). When analyzed statistically for the
entire drug group (Figure 4A; n = 10 with 5 tests at 23◦C and 5
tests at 37◦C), the effect of time was highly significant for glucose
current [F(9,549) = 47.66; p < 0.001] and not significant for null
current. The mean of the null currents was then subtracted from
individual glucose currents, and these values were calibrated
to concentration values based on sensors’ sensitivity corrected
for brain temperature. We found that NAc glucose levels, after
the initial weak drop during the injection (0–4min), rapidly
increased for ∼10min, peaked at 406µM above baseline (range
172–608 or 720–1556µM in terms of absolute concentration),
and slowly decreased toward baseline (Figure 4B). In this data
sample, themean basal concentration of NAc glucose was 707.8±
44.7µM (SD = 134.2µM) and the mean drug-induced increase
was about 60% above baseline.
While the increase was the predominant effect of general
anesthesia, glucose currents initially decreased during the first
4min after the injection onset (Figures 4A,B). This initial effect
was clearly evident and significant when data were analyzed at
a high temporal resolution [Figure 4C, 10-s bins; F(49,196) =
18.99 and 37.50 for cold and warm solutions, respectively; both
p < 0.001]. This effect, however, was absent after saline injection
at the same volume delivered at room temperature, suggesting
its pharmacological nature. Although this inhibiting effect was
stronger when Equithesin was delivered at room temperature (see
Figures 3C,D), group analysis revealed no significant differences
between the groups (Figure 4C). No differences were also seen
in the slow time-course analysis; mean glucose currents in two
groups (23 and 37◦C)were superimposable within the entire drug
effect.
Brain and Body Hypothermia during
General Anesthesia and its Underlying
Mechanisms
Figures 5A,B demonstrates that general anesthesia induced
by iv injection of Equithesin induces robust and prolonged
temperature decreases in the NAc, temporal muscle, and skin
[effect of time; one-way RMANOVA F(61,488) = 12.44, 19.57, and
19.50, respectively; all p < 0.001]. When analyzed at a slow time
resolution (2-min bins), the decrease was strongest in the brain
site (∼1.8◦C), slightly smaller in the muscle (∼1.7), and minimal
in the skin (∼1.2◦C). While generally correlative, temperature
dynamics had important differences in each recording location.
Temperature decreases in the brain weremore rapid and stronger
than in temporal muscle, resulting in a rapid decrease in the
NAc-Muscle differential [Figure 5C; F(61,488) = 13.96; p <
0.001], suggesting decreased intra-brain heat production due
to metabolic brain inhibition. This effect appeared at 5–6min,
peaked at 10–12min, and slowly disappeared within 40–60min
post-injection. In contrast, due to the initial increase in skin
temperature (first 10min post-injection) coupled with a decrease
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FIGURE 4 | Mean (± SEM) changes in NAc electrochemical currents
(A,C) and resulting change in glucose concentration (B) after iv
injection of Equithesin analyzed with slow (2-min bin) and rapid (10-s
bin) time resolution. (A,C) show changes detected by active
(enzyme-containing) and null (enzyme-free) sensors for 120min (A) and 8min
(C) after drug administration. Blue and red values show changes with the drug
delivered at room (23◦C) and body (37◦C) temperatures, respectively. Filled
symbols in each graph indicate values significantly different from the
pre-injection baseline. N is the number of averaged tests.
in muscle temperature, the Skin-Muscle differential (a valid
measure of peripheral vascular tone) rapidly increased from 2–
4min, stabilized at high levels (∼0.7◦C) at 20–80min, and slowly
decreased toward baseline, not reaching it at the final time point
of analysis [effect of time; F(61,488) = 9.24; p < 0.001]. Therefore,
bothmetabolic inhibition and strong skin vasodilation contribute
jointly to anesthesia-induced brain and body hypothermia.
Since the most robust changes in temperature parameters
occurred immediately after injection, the same parameters were
analyzed at a high, 10-s temporal resolution for the initial
8min after the injection onset (Figures 5D–F). Following this
analysis, we found that NAc temperature initially increased
and skin temperature transiently decreased immediately after
the start of the injection but then, at ∼60 s, both curves
inverted and skin temperature began to increase and brain
temperature began to decrease (Figures 5D,E). Importantly, the
increase in Skin-Muscle differential, suggesting vasodilation,
occurred earlier, during the injection. Conversely, the decrease
in NAc-Muscle differential, suggesting decreased intra-brain heat
production, occurred with a longer latency (∼220 s; Figure 5F).
Similar to the subsequent opposite effects, decreases in the Skin-
Muscle temperature differentials occur much quicker (20-30 s
latency) and they are more transient (∼50 s) than the more
tonic increases in the NAc-Muscle differential. Importantly,
changes in NAc-Muscle and Skin-Muscle differentials correlated
tightly (r = −0.964) from the onset of drug injection
(Figure 5F). Therefore, the injection of Equithesin results in
transient and immediate brain activation and vasoconstriction,
followed by opposite effects that occur for a longer period of
time.
Relationships between
Anesthesia-Induced Changes in NAc
Glucose and Temperature Parameters
To understand the possible mechanisms underlying anesthesia-
induced fluctuations in NAc glucose, we next examined how
these changes correlate dynamically with NAc-Muscle and Skin-
Muscle temperature differentials, which show, respectively, drug-
induced changes inmetabolic activity and the tone of skin vessels.
When the data were analyzed at a slow time-resolution (2-
min bin) for the entire period of a significant glucose change
(0–80min), the increases in glucose correlated with decreases in
NAc-Muscle differentials (Figure 6A). The correlation appeared
from ∼3min post-injection, was strong within the entire
duration of glucose elevation (r = −0.936; p < 0.001) and close
to linear. After glucose peaked and descended toward baseline,
the correlation was maintained but became slightly weaker and
less linear. Even stronger correlation between these parameters
(r = −0.971, p < 0.001) was evident when data were analyzed
with high temporal resolution for the initial 8min post-injection
(Figure 6C).
In contrast to the inverse correlation with an index of
metabolic activity, glucose levels directly correlated with
increases in Skin-Muscle differentials (Figure 6B). This
correlation was evident and exceptionally strong from 3 to
12min post-injection (r = 0.997, p < 0.001), when glucose
levels gradually increased, but disappeared after glucose peaked
and descended to baseline. The high linearity and exceptionally
strong correlation between these parameters (r = 0.994,
p < 0.001) was especially evident when data were analyzed
with high temporal resolution for the first 8min post-injection
(Figure 6D).
Temperature and Glucose Responses
Induced by Arousing Stimulation
In contrast to profound hypothermia during anesthesia, arousing
sensory stimulation (presentation and removal of a glass beaker)
slightly increased brain and muscle temperatures and decreased
skin temperatures [Figure 7A; F(51,408) = 20.40, 10.98, and 2.67,
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FIGURE 5 | Changes in different temperature parameters induced by iv injection of Equithesin, shown with slow (A–C; 2-min bin), and rapid (D–F; 10-s
bins) time resolutions. The top graphs (A,D) show absolute changes in NAc, temporal muscle, and skin temperatures; middle graphs (B,E) show relative changes
in these parameters; and bottom graphs (C,F) show changes in NAc-Muscle and Skin-Muscle temperature differentials. Values significantly different from pre-injection
baseline are shown as filled symbols. In (A–C), the moment of injection is shown by a vertical hatched line (0min) with an arrow; in (D–F), duration of injection
(0–120 s) is shown as gray shaded areas. In (F), r is coefficient of correlation determined from 120 to 480 s post injection onset.
respectively; all p < 0.01]. Sensory stimulation also induced
significant but opposite changes in NAc-Muscle and Skin-Muscle
differentials [F(51,408) = 5.02 and 5.41, respectively]. Due to
more rapid and stronger increases in brain temperature, the NAc-
Muscle differential transiently increased, suggesting enhanced
heat production due to metabolic activation. In contrast,
the Skin-Muscle differential rapidly and strongly decreased,
suggesting vasoconstriction (Figure 7B). This effect was rapid
(significant at 2min after beaker presentation), peaking at 3–
7min before slowly returning to baseline.
These differences in speed and intensity of temperature
responses in different recording locations were more evident
following rapid time-course analyses (Figures 7C,D). In this case,
skin temperature showed a significant decrease at the fourth data
point (or 30–40 s from stimulation onset), while increases in
brain and muscle temperatures became significant at 60–70 and
90–100 s after stimulus onset, respectively. Similar differences
in timing and response magnitude were also evident for NAc-
Muscle and Skin-Muscle differentials.
While NAc glucose also increased during novelty test, the
changes were different from those seen during anesthesia
(see original examples Figures 3A,B). Using high time-
resolution analysis (2-s bins), we found that glucose currents
significantly increased [F(91,1001) = 15.05; p < 0.001], while
null currents show no changes (Figure 7E). Transformation
of these current changes into concentration values revealed
that glucose levels rapidly rise, becoming significant from
the second data point (2–4 s) following beaker presentation
(Figure 7F). These increases peaked at ∼15 s and decreased
toward baseline, showing an additional small peak after
beaker removal. In contrast to the high-magnitude glucose
rise seen during the development of anesthesia, this phasic
increase was relatively small in magnitude (∼42µM or
5–10% above baseline). This pattern of the NAc glucose
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FIGURE 6 | Correlative relationships between anesthesia-induced changes in NAc glucose and two primary indices reflecting metabolic activity
(NAc-Muscle differential; A,C) and vascular tone (Skin-Muscle differential; B,D) analyzed with slow (A,B) and rapid (C,D) time resolutions. For
explanations see the text.
response differed significantly from the dynamics of
temperature parameters, which showed much slower but
longer changes.
DISCUSSION
Our present study revealed that NAc extracellular glucose levels
tonically increase during the development of general anesthesia.
These increases tightly correlate with increases in Skin-Muscle
temperature differentials, suggesting that anesthesia-induced
brain hyperglycemia may result from a massive inflow of
glucose from the cerebral vessels due to their vasodilation. This
robust pharmacological effect drastically differs from both the
slow, gradient-dependent glucose increases after consumption of
glucose-containing products and rapid, neural activity-regulated
glucose increases induced by arousing stimuli and occurring
during behaviors and it could explain the existing controversy
regarding basal glucose levels in different animal preparations.
What are the Basal Levels of Extracellular
Glucose in Brain Tissue?
Extracellular glucose could be measured by using microdialysis
(Fellows et al., 1992; Fray et al., 1997; McNay and Gold,
1999; McNay et al., 2001), providing an accurate estimate
of its basal levels and tonic fluctuations. However, this
technique is essentially slow and does not allow for the
detection of rapid fluctuations in glucose levels. This goal
could be achieved by using glucose oxidase-based biosensors
coupled with amperometry (Hu and Wilson, 1997; Wilson and
Gifford, 2005)—an alternative approach for assessing second-
scale fluctuations in extracellular glucose levels (see for review
Kiyatkin andWakabayashi, 2015). While this approach is usually
not instrumental for quantifying basal levels of neurochemicals,
the parallel use of glucose-null sensors, which are equally
sensitive as glucose sensors to multiple physical and chemical
contributors, allowed us to estimate extracellular glucose levels
under physiologically relevant conditions. Our previous (540–
700µM; Kiyatkin and Lenoir, 2012; Wakabayashi et al., 2015)
and current (540–707µM) estimates for the NAc are in line
with previous zero-net-flux microdialysis (470–1000µM Fellows
et al., 1992; Fray et al., 1997; McNay and Gold, 1999; McNay
et al., 2001) and electrochemical estimates (350–600µM (Lowry
and Fillenz, 1997; Netchiporouk et al., 2001; Kealy et al.,
2013) obtained in different brain structures in awake, freely
moving rats. However, these values are much lower than classic
calculated values (2–4mM; Siesjo, 1978; Lund-Andersen, 1979)
and both electrochemical and microdialysis estimates obtained
in anesthetized animal preparations [2.4mM for ventromedial
hypothalamus; Silver and Erecinska, 1994; 3.3mM for cortex
in Ronne-Engström et al. (1995); 2.6mM for hippocampus in
Hu and Wilson (1997)]. Although our present measurements
were limited to the ventral striatum and basal glucose levels
could vary in different brain structures, this study clearly
shows that general anesthesia tonically increases extracellular
glucose well above the levels seen under normal physiological
conditions.
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FIGURE 7 | Mean (± SEM) changes in temperatures (A–D), NAc electrochemical currents (E; orange: glucose and blue: null sensors), and glucose
concentration (F) induced by the novelty test. The rat at time 0 was introduced to a glass beaker, which was removed from the cage at time 60 s. In (A,B), onset
of arousing stimulation is shown as vertical hatched line with arrow and in (C–F), duration of stimulation (0–60 s) is shown as a gray shaded area. Filled symbols in
each graph show values significantly different from baseline.
Physiological Fluctuations in NAc Glucose
and their Mechanisms
Glucose used for brain metabolism arrives from the arterial
blood, where its concentration is maintained at much higher
and relatively stable levels. Due to this concentration gradient,
glucose continuously enters the brain’s environment by facilitated
diffusion via the GLUT-1 glucose transporter (Duelli and
Kuschinsky, 2001). Due to the rise in this concentration gradient,
brain glucose levels substantially increase after consumption of
glucose-containing products (Wakabayashi and Kiyatkin, 2015a)
and systemic or intra-gastric glucose administration (Dash
et al., 2013). In addition to this “passive,” gradient-dependent
mechanism, glucose levels could transiently increase or decrease
in different brain structures due to changes in neuronal activity,
which directly affect the tone of cerebral vessels and local
cerebral blood flow. As shown in this study with a novelty
test (see Figures 3, 4), NAc glucose rapidly rises and peaks
within seconds after the presentation of a novel object and
quickly returns to baseline, showing a small second peak after
the novel object’s removal. Importantly, glucose rises well before
and much faster than increases in NAc-Muscle temperature
differential, suggesting rapid neural regulation of this response
that precedes the increases in intra-brain heat production due
to metabolic brain activation (see Figure 7). Therefore, due
to the efficient neuro-vascular coupling, the brain is able to
receive energetic substances (glucose and possibly oxygen) for
its metabolic activity well in advance of any actual demand, thus
preventing possible metabolic deficit. In contrast to “passive”
gradient-dependent glucose entry into brain tissue, which has
been shown to similarly affect different brain structures, neural
activity-triggered fluctuations in glucose are structure-specific,
as shown previously by comparing the ventral striatum and
substantia nigra pars reticulata (Kiyatkin and Lenoir, 2012). Most
neurons in the NAc have slow, sporadic discharges, and show
phasic excitations to sensory arousing stimuli (Kiyatkin and
Rebec, 1996, 1999), and glucose levels are phasically increased
by these stimuli. Conversely, glucose levels phasically decrease in
pars reticulata, where most neurons have high activity rate and
show phasic inhibitions following sensory stimulation (Schultz,
1986; Windels and Kiyatkin, 2004).
Anesthesia-Induced Brain Hyperglycemia
and its Mechanisms
The robust tonic rise in NAc glucose following the development
of general anesthesia could represent another mechanism of
glucose entry into the brain extracellular environment. An
exceptionally strong correlation between this glucose response
and an index of vasodilation could suggest that this effect is
mediated by anesthesia-induced cerebral vasodilation, which
enhances glucose entry even with minimal changes or even
decreases in local cerebral flow typical of anesthesia (Mishra,
2002). In this study we examined the NAc glucose response
induced by an iv-delivered mixture of pentobarbital and
chloral hydrate, but increases in extracellular glucose have
been previously reported with different anesthetic drugs (i.e.,
pentobarbital, chloral hydrate, ketamine+xylazine, isoflurane),
in different brain structures, and by using both microdialysis
(Fellows et al., 1992; Canal et al., 2005) and electrochemical
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detection (Osborne et al., 1997; Lowry et al., 1998; Netchiporouk
et al., 2001; Dash et al., 2013; Kealy et al., 2013). Although
the magnitude of these increases varied for different drugs
in different studies, the consistency of this effect may suggest
that brain hyperglycemia occurs during the development of
general anesthesia independently of the type of anesthetic drug.
Importantly, glucose levels strongly increased during anesthesia
induced by pentobarbital (Osborne et al., 1997; Canal et al.,
2005; our unpublished data), a known inhibitor of metabolic
brain activity that induces robust brain and body hypothermia
(Kiyatkin and Brown, 2005).
Similar to the large-magnitude effects found in previous
studies, our quantitative analysis revealed that the NAc glucose
increase induced by Equithesin is strong, exceeding 60% of
quiet-resting baseline and moving absolute glucose levels in this
structure to 720–1556µM. High-magnitude effect of anesthesia
is also indirectly supported by data obtained in anesthetized
animal preparations, which revealed unusually high “basal” levels
of extracellular glucose (2.4–3.3mM, Silver and Erecinska, 1994;
Ronne-Engström et al., 1995; Hu and Wilson, 1997). Despite
the consistency of this phenomenon, its underlying mechanisms
remained a matter of speculation.
To explore the possible mechanisms of this phenomenon, our
glucose recordings were supplemented by high-speedmonitoring
of brain, muscle, and skin temperatures. While anesthesia-
induced decreases in brain and body temperature is a well-
known phenomenon (Lenhardt, 2010), the three-point recording
paradigm used in this study allowed us to assess two basic
mechanisms (intra-brain heat production due to metabolic
brain activation and changes in vascular tone) underlying the
hypothermic effects of general anesthesia. By using correlation
and regression analyses, we found that the ascending phase
of NAc glucose rise tightly correlates with increases in Skin-
Muscle differentials, which indicate peripheral vasodilation. This
correlation appeared ∼150 s after the start of 120-s injection
and was exceptionally strong (r => 0.99) and linear for the
entire ascending phase of the glucose increase. Since the tone
of cerebral vessels is the primary factor affecting glucose entry
into brain tissue, this rise could reflect the enhanced glucose
entry from the arterial blood due to dilation of cerebral vessels.
While the direct data on the vascular response in the NAc
are absent, vasodilation confirmed in this study at the level of
peripheral vessels could also occur at the level of cerebral vessels
(ter Laan et al., 2013). Although, it has been previously speculated
that anesthesia-induced brain glucose rise could be dependent
upon the rise in blood glucose levels, direct measurements
during pentobarbital and ketamine-xylazine anesthesia revealed
that increases in blood glucose are incomparably weaker and,
most importantly, much slower than those seen in the brain
(Canal et al., 2005). Furthermore, as shown in our previous
study employing iv injections of glucose (Wakabayashi et al.,
2016), increases in NAc glucose are relatively small after transient
doubling (∼15%) or even tripling (∼35%) of blood glucose levels.
While extracellular glucose could phasically rise due to
local neural activation and subsequent vasodilation and this
mechanism was confirmed here in our novelty test (see above),
it is unlikely that this factor is involved in mediation of brain
hyperglycemic response becausemost anesthetic drugs, including
pentobarbital and chloral hydrate, are known to inhibit the
activity of ventral striatal neurons (West, 1998; Chen et al.,
2001; Windels and Kiyatkin, 2006). Finally, it is unlikely that
drug-induced metabolic inhibition per se could be a mechanism
determining the strong rise in glucose seen in this study.
Although our thermorecording data suggest that Equithesin
anesthesia decreases brain metabolic activity, this effect develops
with some latency and is weaker than vasodilation. However,
glucose changes strongly and negatively correlated with decreases
in the NAc-Muscle differential (r =>0.97), suggesting that
glucose rise is related to metabolic inhibition. While it is possible
to speculate that the diminished glucose uptake by brain cells
(i.e., metabolic inhibition) could shift the balance of extracellular
glucose levels to their increase, it is unclear how this cellular
change could account for the robust rise in glucose during
the development of general anesthesia. A possible explanation
could arise when we look at the relationship between anesthesia-
induced metabolic inhibition and vasodilation, which also tightly
correlated (r = −0.96) from ∼2min post drug injection
(see Figure 5), suggesting interrelatedness between these two
parameters and their corresponding physiological mechanisms.
Therefore, both metabolic brain inhibition and vasodilation
could be two different but related effects induced by central
actions of anesthetic drugs.
Local Action of the Anesthetic Drugs
during the Injection
In addition to the primary effect of anesthesia, high-speed
analysis of electrochemical signals revealed that the NAc glucose
rise is preceded by a transient decrease in NAc glucose during the
injection (see Figures 3, 4). As confirmed with our control tests
using equal-volume saline injections and different temperatures
of the injected drug, this effect has a pharmacological origin.
While further studies are necessary to clarify the mechanisms
underlying this transient effect, it appears that it is triggered
by the local action of the injected drug on the afferents of
sensory nerves that densely innervate the internal walls of veins
and the heart atrium (Lee et al., 2005). This visceral sensory
stimulation creates an ascending neural signal that is rapidly
transmitted to the CNS and induces a transient vasoconstriction
that could determine a transient drop in glucose levels. In support
of this mechanism, a transient vasoconstriction was observed
during high-resolution analysis of our thermorecording data (see
Figures 5D–F). It is important to note that this transient effect
could not be detected with slower measurement techniques (i.e.,
microdialysis) and it even almost disappears with a slow time
resolution analysis of the electrochemical data.
Functional Implications
The two primary mechanisms that determine glucose entry into
brain tissue (i.e., via a “passive” rise in blood-brain gradient
and “active” neuro-vascular coupling) could explain changes
in extracellular glucose occurring under normal physiological
conditions. As shown in this study, anothermechanism involving
metabolic brain inhibition and vasodilation is engaged during
general anesthesia, resulting in strong brain hyperglycemia.
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While in this study our measurements were limited to the
NAc, an area with high-density of GLUT-1 transporters (Zeller
et al., 1997), evidence from existing literature suggests that this
phenomenon could occur to different extent in other brain
structures, thus explaining the existing controversy regarding
basal glucose levels in different animal preparations. The
powerful effects of general anesthetics on brain metabolic
activity, the tone of peripheral and central vessels, and the entry
of glucose into the extracellular domain also question the validity
of physiological evaluations of these processes conducted in
anesthetized animal preparations. While the direct relationships
between metabolic brain activation, increased cerebral blood
flow, and entry of glucose and oxygen into brain tissue generally
hold under normal physiological conditions, these relationships
become much more complex and can alter drastically following
exposure to pharmacological drugs that have distinct effects on
these physiological processes.
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